{
    "nctId": "NCT06299930",
    "briefTitle": "Locoregional Recurrence After Neoadjuvant Versus Adjuvant Chemotherapy",
    "officialTitle": "Locoregional Recurrence After Neoadjuvant Versus Adjuvant Chemotherapy Based on Tumor Subtypes in Patients With Early-stage Breast Cancer: A Multi-institutional Retrospective Cohort Study",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 10328,
    "primaryOutcomeMeasure": "Locoregional recurrence-free survival (LRR)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients who underwent breast-conserving surgery for invasive breast cancer between 2004 and 2018\n\nExclusion Criteria:\n\n* Total mastectomy\n* No pre- or postoperative chemotherapy\n* No radiation therapy\n* Bilateral breast cancer\n* Male breast cancer patients\n* Secondary breast cancer\n* Metachronous or synchronous cancers",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}